featured
ctDNA as a Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)
Clin. Cancer Res 2017 Jun 02;[EPub Ahead of Print], F Garlan, P Laurent-Puig, D Sefrioui, N Siauve, A Didelot, N Sarafan-Vasseur, P Michel, G Perkins, C Mulot, H Blons, J Taieb, F Di Fiore, V Taly, A ZaananFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.